FDA Names Commissioner to Replace Crawford; Prolexys, Pathways Diagnostics, Assay Designs Taps New CEOs; UCSC s Haussler Awarded Dickson Prize; GenoLogics and Genizon Build Management Teams; and Others | GenomeWeb

Andrew von Eschenbach  has been named acting commissioner of the US Food and Drug Administration , following the resignation of former commissioner Lester Crawford last week.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.